Leo Mascarenhas
Cedars-Sinai Medical Center(US)
Publications by Year
Research Areas
Sarcoma Diagnosis and Treatment, PI3K/AKT/mTOR signaling in cancer, Chronic Myeloid Leukemia Treatments, Neuroblastoma Research and Treatments, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children(2018)2,654 cited
- → Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1/2 clinical trials(2020)963 cited
- → Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort(2019)709 cited
- → Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study(2018)540 cited
- → Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial(2016)517 cited
- → Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group(2012)324 cited
- → Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma(2019)254 cited
- → Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi‐modality therapy: A report from the Children's Oncology Group(2008)200 cited
- → Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children’s Oncology Group(2018)170 cited
- → Systemic Exposure to Thiopurines and Risk of Relapse in Children With Acute Lymphoblastic Leukemia(2015)148 cited